Insiders · CLOV

Joseph Clay Thornton

Interim CFO at Clover Health Investments, Corp. /de (CLOV)

Joseph Clay Thornton has filed 5 insider reports with the SEC since April 2026, as interim CFO at Clover Health Investments, Corp. /de (CLOV). In the last 12 months Joseph Clay Thornton sold $99.7K of stock on the open market. In the latest filing, on August 17, 2026, Joseph Clay Thornton sold 17,775 shares of Clover Health Investments, Corp. /de (CLOV) for $78K at an average of $4.39.

Filings
5
Companies
1
Bought on market
None
Sold on market
$99.7K

Companies where Joseph Clay Thornton is an insider

CompanyRoleShares heldBoughtSoldLast filing
CLOV Clover Health Investments, Corp. /deInterim CFO1,249,526$99.7KAug 17, 2026

Shares held: common shares owned directly after the latest filing that states it.

Every filing

Other insiders at the same companies

Questions about Joseph Clay Thornton

What is Joseph Clay Thornton's role at Clover Health Investments, Corp. /de?
Joseph Clay Thornton reports to the SEC as interim CFO at Clover Health Investments, Corp. /de (CLOV), according to the latest filing on August 17, 2026.
How many shares does Joseph Clay Thornton own?
After the latest filing that states it, Joseph Clay Thornton directly owned 1,249,526 shares of Clover Health Investments, Corp. /de (CLOV). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Joseph Clay Thornton bought or sold stock recently?
The most recent open-market sale was on August 17, 2026: sold 17,775 shares of Clover Health Investments, Corp. /de (CLOV) for $78K at an average of $4.39.
How do I get alerts when Joseph Clay Thornton files?
Follow Joseph Clay Thornton on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5. Joseph Clay Thornton filed 2 times in the last 90 days.

From SEC Forms 4 and 5 filed by Joseph Clay Thornton (SEC CIK 0002128794). Totals count each trade once, skipping amendments whose original is on file, from Apr 16, 2026 on. View on SEC EDGAR